BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 12212931)

  • 1. Managing the behavior of the medically insured in Germany: the acceptance of cost-sharing and risk premiums by members of the statutory health insurance.
    Ullrich CG
    J Health Soc Policy; 2002; 15(1):31-43. PubMed ID: 12212931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determinants of health care utilization by German sickness fund members--with application to risk adjustment.
    Breyer F; Heineck M; Lorenz N
    Health Econ; 2003 May; 12(5):367-76. PubMed ID: 12720254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. American health policy: cracks in the foundation.
    Nyman JA
    J Health Polit Policy Law; 2007 Oct; 32(5):759-83. PubMed ID: 17855716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Options for a future risc structure compensation in Germany].
    Greiner W
    Gesundheitswesen; 2006 Jul; 68(7):442-8. PubMed ID: 16868871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Factors Influencing Participation in Financial Incentive Programmes of Health Insurance Funds. Results of the Study 'German Health Update'].
    Jordan S; von der Lippe E; Starker A; Hoebel J; Franke A
    Gesundheitswesen; 2015 Nov; 77(11):861-8. PubMed ID: 25536225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aligning incentives using risk-sharing arrangements.
    Lefton R
    Healthc Financ Manage; 1997 Feb; 51(2):50-2, 54-7. PubMed ID: 10164877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bankruptcy is the tip of a medical-debt iceberg.
    Seifert RW; Rukavina M
    Health Aff (Millwood); 2006; 25(2):w89-92. PubMed ID: 16507557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Managed care: practice, pitfalls, and potential.
    Wallack SS
    Health Care Financ Rev Annu Suppl; 1991; ():27-34. PubMed ID: 10117117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal quality, waits and charges in health insurance.
    Gravelle H; Siciliani L
    J Health Econ; 2008 May; 27(3):663-74. PubMed ID: 18191254
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Introduction of disease management programmes in Germany as reflected by differing interests of health insurance companies and the federal association of statutory health insurance physicians].
    Erler A
    Gesundheitswesen; 2002 Nov; 64(11):572-7. PubMed ID: 12442215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benefit-incidence analysis of government spending on Ministry of Health outpatient services in Jordan.
    Halasa Y; Nassar H; Zaky H
    East Mediterr Health J; 2010 May; 16(5):467-73. PubMed ID: 20799544
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the assets of uninsured households to cost sharing under high-deductible health plans.
    Jacobs PD; Claxton G
    Health Aff (Millwood); 2008; 27(3):w214-21. PubMed ID: 18413333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optimal cost reimbursement of health insurers to reduce risk selection.
    Kifmann M; Lorenz N
    Health Econ; 2011 May; 20(5):532-52. PubMed ID: 20572200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Wealth, income, and the affordability of health insurance.
    Bernard DM; Banthin JS; Encinosa WE
    Health Aff (Millwood); 2009; 28(3):887-96. PubMed ID: 19414902
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of premium, copayments, and health status on the choice of health plans.
    Naessens JM; Khan M; Shah ND; Wagie A; Pautz RA; Campbell CR
    Med Care; 2008 Oct; 46(10):1033-40. PubMed ID: 18815524
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysing the impact of health-care system change in the EU member states--Germany.
    Wörz M; Busse R
    Health Econ; 2005 Sep; 14(Suppl 1):S133-49. PubMed ID: 16161188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk selection in the German public health insurance system.
    Nuscheler R; Knaus T
    Health Econ; 2005 Dec; 14(12):1253-71. PubMed ID: 15942977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pricing-out effect from possible user-fee policies under Taiwan's National Health Insurance.
    Chen WY; Liang YW; Lin YH
    Expert Rev Pharmacoecon Outcomes Res; 2010 Aug; 10(4):453-64. PubMed ID: 20715921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons from the first to the latest nation to enact national health insurance.
    Eastaugh SR
    J Am Health Policy; 1992; 2(6):32-4. PubMed ID: 10122416
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Switching sickness funds and risk compensation mechanisms in the statutory health insurance system in Germany--empirical results from the cooperative health research in the region of Augsburg (KORA)].
    Werner A; Reitmeir P; John J
    Gesundheitswesen; 2005 Aug; 67 Suppl 1():S158-66. PubMed ID: 16032535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.